Introduction
Atopic asthma is a disease of dysregulated immune system affecting children and young adults. It is a complex disorder with variable phenotype and aberrant Th1/Th2 cytokine profile. 1, 2 Interferon-gamma (IFNg) is an important Th1 cytokine and shown to regulate multiple features of asthma pathogenesis, such as suppression of Th2 cytokine release, 3 inhibition of effector cell recruitment to the site of inflammation, induction of apoptosis in T cells, eosinophils and mucusstoring cells, blockage of IgE isotype switch in B cells, etc. 4 It has been shown that low levels of IFNg predispose children to atopic asthma. 5 Also, it is normalization of IFNg-mediated responses and not reduction in Th2 cytokines that reverses the asthma features. 6 Like most of the cytokines, IFNg gene coding region has been found to be invariant; 7 however, some polymorphisms such as (CA)n repeat in intron 1, þ 874A/T (which is found to be in absolute linkage disequilibrium (LD) with CA (16) repeat) 8 and À179T/G have been identified in the non-coding region of this gene and shown to be associated with pathological features of asthma, 9 diabetes, 10 tuberculosis 11 and several other chronic inflammatory and autoimmune disorders. The (CA)n repeat modulates IFNg levels in vitro 12 and has been shown to be associated with many Th1/Th2-mediated disorders. 13 Despite the fact that IFNg plays a vital role in asthma etiopathophysiology, at present, there are limited studies that have investigated the role of polymorphisms in this gene in asthma pathogenesis, and the results reported are inconsistent. The (CA)n repeat polymorphism was found to be associated with childhood asthma in Japanese population 9 in one study, whereas in another study 14 from the same population it was not. Nakao et al. 9 have used allele frequency difference of allele 5 (16 repeats) to calculate the deviation of distribution between cases and controls and when Shao et al.
14 pooled their data with the former they found no statistical significance after correction for multiple testing (P40.05). In Indian population, in a case-control study, we had reported this (CA)n repeat to be associated with asthma and serum total IgE levels. 15 The inconsistencies in the results obtained could be due to ethnic variations that persist in different populations, study design and patient selection criteria. In any event, there still remains a possibility that some other polymorphism in this gene might be playing an important role in asthma pathogenesis, as linkage studies have detected strong signals around this gene and asthma. 16 To explore this, we further genotyped six single nucleotide polymorphisms (SNPs) in this gene (one in promoter region, three in intron and two downstream of 3 0 untranslated region) along with the (CA)n in a case-control and a family cohort. We have analyzed the association of the repeat polymorphism and SNPs independently and at the level of haplotype with asthma and total serum IgE. We found significant association of an intronic SNP with asthma. Furthermore, using electrophoretic mobility shift assay, we identified a nuclear factor binding site in the region of ss2 A/G (rs1861494) that may regulate the expression of IFNg.
Results
We genotyped the (CA)n repeat and six SNPs in a total of 625 individuals from 137 extended families for our family-based study design. Additionally, for case-control studies, 189 patients and 270 normal controls were genotyped. Serum total IgE was estimated for all the individuals except for 5% of the parents and 3% of controls where sera were not available. The mean logarithmic total serum IgE levels were 2.80±0.67 and 2.31 ± 0.60 for patients and controls, respectively, and were found to be significantly different between the two groups (P ¼ 0.0001). The mean logarithmic total serum levels of probands (family samples) were 2.9±0.66 (Supplementary Table A) .
SNPs and LD
Hardy-Weinberg equilibrium (HWE) was calculated on the basis of observed and predicted heterozygosity of each SNP. We observed a slight deviation from HWE for ss4 (Po0.05) in asthmatics in our case-control cohort, whereas for the rest of the SNPs no deviation from HWE was observed (P40.05). We calculated pairwise LD of the six SNPs using Haploview. A modest to very high inter-marker LD was observed between the SNPs ( Figure 1 ). As ss2 and ss3 were found to be in complete LD (D 0 ¼ 1.0, r 2 ¼ 0.98), we genotyped only the ss2 A/G polymorphism.
Association of IFNg polymorphism with asthma Earlier, we had shown a (CA)n repeat in intron 1 of this gene to be associated with asthma and serum total IgE levels in our case-control study design. 15 In this study, we did not observe any association with asthma or serum total IgE either in the case-control study (data not shown) or in our family study (Supplementary Table C) .
We found a significant difference in the distribution of ss2 A/G alleles between cases and controls ( Table 1) . The ss2-G was negatively associated with asthma (P ¼ 0.0006), hence protective (odds ratioo1). The significance was retained even after Bonferroni correction (P ¼ 0.003). At the level of genotype, an increase in risk was observed when AG was changed to AA for this polymorphism. Genotype AA was positively associated with asthma (odds ratio ¼ 1.99; P ¼ 0.002) ( Table 1) . Furthermore, regression analysis with age and sex did not have any effect on the significance of association (data not shown). In family studies as well, ss2 (A/G) polymorphism showed positive association with asthma in multi-allelic, additive model of FBAT analysis (global w 2 ¼ 7.59; P ¼ 0.006) ( Table 2 ). The bi-allelic, additive model of FBAT detected significant overtransmission of allele A (P ¼ 0.006) to asthmatics, whereas allele G was found to be significantly undertransmitted to the normal controls. Association was also observed at genotypic level (global w 2 ¼ 8.62; P ¼ 0.01), which remained significant after correction for multiple testing (P ¼ 0.05). Individually, genotype AA was significantly (P ¼ 0.003) overtransmitted to asthmatics, whereas genotype AG was significantly undertransmitted (P ¼ 0.008) (data not shown). Furthermore, these results were replicated in TDT-sTDT analysis as well ( Table 2) .
Association of IFNg polymorphisms with log 10 serum total IgE levels Total serum IgE levels were found to follow a log normal distribution. When cases and controls were compared with respect to the log total serum IgE levels, a highly IFNc gene polymorphisms and asthma A Kumar and B Ghosh significant difference was obtained (P ¼ 0.0001). We found a significant association for ss2 polymorphisms (P ¼ 0.02) with IgE levels in asthmatic patients in our case-control cohorts when analyzed using analysis of variance, but the significance was lost after regression analysis with age and sex as covariates (data not shown). Using orthogonal model of QTDT, we did not find any significant association with either the microsatellite repeat or SNPs in the families as well (data not shown).
Haplotype association with asthma Five-locus haplotypes were generated using the SNPs, as inclusion of the (CA)n resulted in a large number of haplotypes with frequency less than 5%. In our case-control cohort, haplotypes generated using PHASE 2.1 were significantly different in their frequency of distribution between cases and controls (P ¼ 0.01) ( Figure 2 ). As counts per haplotypes were very low, CLUMP version 2.2 with 1 000 000 Monte-Carlo simulations was used. There was a significant difference in haplotype distribution between patients and controls when haplotypes with small expected value were clumped together ((T2) (
. In our family-based haplotypic studies as well, we found significant transmission distortion between cases and controls (global Table 3) . Apart from five-locus haplotypic analysis, a three-locus sliding window analysis was also performed. Haplotypes with the (CA)n repeat, ss2 (A/G) and ss4 showed the most significant score in our case-control cohort Table 4 ), suggesting that this region could be the region of highest priority for asthma pathogenesis.
Allele-specific binding of nuclear proteins to IFNg ss2 A/G polymorphic site To test if ss2 A/G substitution, which showed association with asthma, could have any effect on the binding of nuclear proteins, we carried out electrophoretic mobility shift assay using nuclear extracts prepared from Jurkat T cells stimulated or not with lipopolysaccharide for 45 min and oligonucleotides containing A or G variant (as detailed in Supplementary Information). We did not observe any difference in binding between uninduced and lipopolysaccharide-induced nuclear extracts (Figure 3 , complex 'a', lanes 2 and 3). However, there were distinct differences in binding affinity between the wild-type (A) probe (Figure 3a , protein complex 'a', lanes 2 and 3) and polymorphic (G) probe (Figure 3a , protein complex 'a', lanes 4 and 5), with the wild-type allele having a higher binding affinity than the polymorphic allele (Figure 3a , protein complex 'a', compare lanes 2 and 3 with lanes 4 and 5). The specificity of binding was confirmed using cold-chase experiments, wherein a 100-fold molar excess of unlabeled specific probes inhibited the complex formation (Figure 3a , protein complex 'a', lanes 6 and 9) whereas similar concentrations of irrelevant unlabeled probes such as nuclear factor-kB and Oct1 could not (Figure 3a , protein complex 'a', lanes 7, 10 and 8, 11 respectively). To further confirm differential affinity of binding, we carried out competition experiments where labeled probe A was chased with unlabeled probes A and G at varying concentrations (Figure 3b ). Unlabeled probe A at a 75-fold molar excess of labeled probe A was able to chase out a considerable amount of the DNA-protein complex 'a' (Figure 3b , lane 6), whereas a 125-fold molar excess of unlabeled polymorphic probe G was required to chase out to a similar extent (Figure 3b, lane 13) . Thus, the results from Figures 3a and b suggest that the wild-type allele (A) has a higher binding affinity than the polymorphic allele (G) for binding to putative nuclear factor(s).
Discussion
In this study, we have investigated six SNPs (reported to be associated with other autoimmune and inflammatory disorders but not with asthma) along with a CA repeat polymorphism in a family-based and case-control cohort, and provide evidence that intronic polymorphisms play an important role in asthma pathogenesis. Particularly, we have identified the A-G substitution (ss2) in intron 3 of this gene to be associated with asthma both at the allelic and the genotypic levels (Tables 1 and  2 ). Also, in our haplotype analysis, which is of higher informative value to assess the contribution of genetic polymorphisms in diseases, 17 we observed a significant association in both the cohorts. Interestingly, haplotypes with allele A (ss2 A/G) appear with a higher frequency in asthmatics than in controls, whereas haplotypes with allele G are found to be in a higher frequency in normal controls than in asthmatics ( Figure 2 and Table 3 ). This provides further evidence for the involvement of ss2 A/G polymorphism in asthma pathogenesis.
Association studies with the (CA)n repeat in this gene have found inconsistent results across different populations. As this (CA)n repeat did not show any association in our case-control or family-based Figure 2 Histogram showing the distribution of haplotypes in cases and controls. Haplotypes were generated using PHASE 2.1, and their relative frequencies were compared between cases and controls. The overall difference was significant (P ¼ 0.01) when 1 million simulations were applied using Monte-Carlo approach. Table C) analysis, there is a possibility that our earlier case-control 15 analysis could have shown a false-positive association. Nevertheless, our current results strongly suggest that individually the repeat may not have any significant effect, but in combination with other polymorphisms, namely, ss2 A/G and ss4 C/T, it might play a significant role. This is supported by our sliding window haplotypic analysis, where the most significant P-value was scored with the CA repeat in intron 1, ss2 A/G and ss4 C/T in intron 3, in our case-control (Supplementary Table D) and family (Table 4 ) study as well.
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IFNc gene polymorphisms and asthma
It is interesting to note that the ss2 (A/G) polymorphism, which showed association with asthma, is located in intron 3, which was earlier shown to possess enhancer activity and also contain a T-box binding element. 3 Our electrophoretic mobility shift assay experiment provides a clue to the functional role of ss2 A-G substitution. The results obtained indicate that allele G strongly influences the binding of a nuclear protein at this locus ( Figure 3 ) and may regulate the expression of IFNg. Using MatInspector (http://www.genomatix.de/cgi-bin/./ eldorado/main.pl) 18 and Transcription Element Search System (http://www.cbil.upenn.edu/cgi-bin/tess/), 19 we identified differential binding of putative nuclear factors, such as RU49 (zinc-finger transcription factor RU49, zinc-finger proliferation 1 (Zipro 1)), EKLF (basic and erythroid kruppel like factors), MZF1 (myleoid zincfinger 1 factor), LVc (leukemia virus factor c) and GAL4 (galactokinase galactose epimerase 4), due to ss2 A-G substitution. Therefore, one or more of these putative transcription factor(s) may bind to this region and regulate IFNg transcription. It is also interesting to note that many genes including IL4 20 and FOXP3 21 intronic regions contain important transcription factor binding sites for their transcriptional regulations. Thus, identification of the nuclear factor binding to this region would be important for understanding the role of ss2 A-G polymorphism in IFNg regulation.
To functionally correlate the effect of these polymorphisms on gene expression, we measured IFNg and interleukin-4 levels in peripheral blood mononuclear cells of 60 subjects. However, we could not find any significant association with either IFNg levels or interleukin-4/IFNg ratio (data not shown). This result is not surprising as we have used peripheral blood mononuclear cells, which contain many cell types. However, it is likely that the ss2 A-G polymorphism identified to be associated with asthma in this study could be regulating gene expression in a cell type-or tissue-specific way. Further studies such as reporter gene assays could be undertaken to study the regulatory potential of this polymorphism on IFNg gene expression. Moreover, the possibility of involvement of another functional polymorphism in strong LD with ss2 polymorphism cannot be ruled out.
Here, we have conducted a case-control study that could provide better direction on promising loci 22 for complex disorder mediated by multiple interacting genes, each with a small effect. Our asthmatics and normal controls are from genetically homogeneous population, as has been established by genotyping loci, yet unlinked to asthma or related atopic disorders (see Supplementary Information) . This provides favorable evidence that our results with IFNg gene regions are not due to stratification or an inherent statistical bias. Moreover, the additional unlinked regions used as controls could only substantiate our results. [23] [24] [25] Furthermore, the power of our case-control study was about 80% for an a value (significance level) of 0.05 and a genotyping error rate of 1% for ss2 SNP, whereas it was more than 80% for the rest of the SNPs. Therefore, it is very unlikely that our results are biased toward type I or type II error. Also, the results obtained have been replicated in family-based studies, which further supports our results.
In brief, this is the first study examining the role of IFNg gene polymorphisms spanning the whole gene, and to the best of our knowledge except for the (CA)n repeat none of them have been studied in relation to asthma before this. We identified an SNP rs1861494 A/G in intron 3 to be associated with asthma and it showed differential binding affinity for a nuclear factor. In addition, this is the first haplotypic association study, to the best of our knowledge, of IFNg gene with asthma and we report a region of high significance. Therefore, our study may initiate further research on elucidating the role of rs1861494 A/G in intron 3 in the regulation of IFNg gene expression and in asthma pathogenesis.
Materials and methods
Subjects
In the present study, asthmatic patients (n ¼ 189, mean age ¼ 37.86±17.08 years) and controls (n ¼ 270, mean age ¼ 34.74 ± 14.4 years) were recruited from our collaborating centers following clinician's diagnosed asthma Total IgE estimation Sera were separated from blood, and total IgE levels were estimated by using the human IgE quantification kits (Bethyl Laboratories Inc., Montogomery, TX, USA), as described earlier.
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Identification of polymorphisms NCBI data search was carried out to identify polymorphisms already reported in other populations. Polymorphisms were selected based on their frequency and efforts were made to select them uniformly through the gene (see the schematic diagram in Figure 1 and Supplementary Information).
Data analysis
Haploview 26 was used to evaluate LD between all the identified SNPs. Single-marker association between phenotype and genotype in case-control study design was tested using Armittage trend test, following the guidelines by Sasieni 27 as implemented in the program FINETTI (http://ihg.gsf.de/linkage/download/finetti. zip). This test makes no assumption about HWE and therefore has lesser chances of obtaining false-positive association even in the absence of HWE. It has been suggested that it is more beneficial than the usual w 2 -test. For total serum IgE levels, linear trends were tested in analysis of variance models of log-transformed values.
Haplotypes were estimated in cases and controls using PHASE 2.1, which uses a Bayesian approach incorporating a priori expectations of haplotypic structure from population genetic and coalescent theory to calculate the association statistics to compare the frequency in cases and controls 28 and differences in haplotype frequencies were also compared in the two groups using a MonteCarlo approach, by performing repeated simulations (1 million in this case) as implemented in CLUMP version 2.2.
29 JMP software package 30 was used to do regression analysis and calculation of frequency difference of alleles, genotypes and haplotypes between cases and controls. Family-based association tests were conducted using TDT-sTDT; however, as it has been suggested to be susceptible to confounding by phenocopies or heterogeneity, 31 we also analyzed our data using FBAT (http://www.biostat.harvard.edu/~fbat/ fbat.htm). FBAT is a robust approach for family-based association analysis and extends the methodology of transmission disequilibrium test to evaluate nuclear families including both affected and unaffected offspring. Each family's contribution to the score statistic is calculated conditioned on parental genotype and offspring's phenotype. It allows for missing parental data and remains robust to population stratification and population admixture. 32 Total serum log 10 IgE levels were analyzed using the QTDT (http://www.sph.umich. edu:80/csg/abecasis/QTDT). Haplotype FBAT or HBAT (http://www.biostat.harvard.edu/~fbat/fbat.htm) was used for assessing multi-locus haplotypes and their transmission in the families. We used program PAWE 33 (http://linkage.rockefeller.edu/pawe/pawe.cgi) to test Figure 3 Analysis of the differential binding of nuclear proteins to A and G alleles of interferon-gamma ss2 A-G polymorphism by electrophoretic mobility shift assay, as described in Materials and methods. Nuclear extracts prepared from uninduced and lipopolysaccharide-induced Jurkat T cells were incubated with 32 P-end-labeled double-stranded nucleotides representing A and G variants. (a) Lanes 1-3 and 6-8 show interaction with allele A, whereas lanes 4, 5 and 9-11 show interaction with G allele. Lane 1 indicates free probe without the nuclear extract; lanes 6 and 9 show binding when the nuclear extract was preincubated with unlabeled A and G probes, respectively; lanes 7, 8 and 10, 11 show complexes formed when the nuclear extract was preincubated with unlabeled, non-relevant nuclear factor-kB and Oct1 probes, respectively. (b) Lane 1 represents free probe, lane 2 is DNA-protein interaction between labeled A probe and nuclear extract, whereas lane 3 represents complex formation when the nuclear extract was preincubated with unlabeled Oct1 probe; lanes 4-8 show complex formation when the nuclear extract was preincubated with increasing concentrations of unlabeled A probe, whereas lanes 9-13 represent DNA-protein interaction when the nuclear extract was preincubated with increasing concentrations of unlabeled G probe.
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